Literature DB >> 31928257

Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool.

Gianpiero Tebano1, Yosra Mouelhi2, Veronica Zanichelli3, Alexandre Charmillon4, Sébastien Fougnot5, Alain Lozniewski6, Nathalie Thilly2,7, Céline Pulcini2,4.   

Abstract

Introduction: Selective reporting of antibiotic susceptibility testing (AST) results is a potentially interesting tool for antibiotic stewardship. It consists of performing AST according to usual practices, but the results are reported to the prescriber only for a few antibiotics (i.e. first-line agents) or not reported at all when colonization is likely.Areas covered: We retrieved 20 studies exploring the impact of selective reporting. Overall, selective reporting is able to influence antibiotic use, both discouraging prescription in case of colonization, and promoting the selection of narrow-spectrum agents. Most studies concerned urine samples. Evidence on the impact on antibiotic resistance is insufficient. Unintended consequences were not observed, but evidence on this topic is scarce. Selective reporting is well implemented in a few countries, and a huge heterogeneity of practices exists.Expert opinion: Evidence shows that selective reporting can help reducing inappropriate and unnecessary antibiotic prescriptions. Uncomplicated urinary tract infections are probably the best initial target, both in hospital and community settings, but other non-severe infections can be a suitable option. The implementation of selective reporting should be promoted by the scientific community, with detailed practical guidelines, and its impact should be further assessed in large interventional studies.

Keywords:  Antibiotic susceptibility testing; antibiotic use; antimicrobial stewardship; cascade reporting; selective reporting

Mesh:

Substances:

Year:  2020        PMID: 31928257     DOI: 10.1080/14787210.2020.1715795

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  5 in total

1.  Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance.

Authors:  Laura Heireman; Stien Vandendriessche; Liselotte Coorevits; Franky Buyle; Jan De Waele; Dirk Vogelaers; Bruno Verhasselt; Jerina Boelens
Journal:  Eur J Hosp Pharm       Date:  2022-03

2.  The Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study.

Authors:  Rama Alkhawaldeh; Rana Abu Farha; Khawla Abu Hammour; Eman Alefishat
Journal:  Antibiotics (Basel)       Date:  2022-05-06

Review 3.  Diagnostic Stewardship as a Team Sport: Interdisciplinary Perspectives on Improved Implementation of Interventions and Effect Measurement.

Authors:  Kyle D Hueth; Andrea M Prinzi; Tristan T Timbrook
Journal:  Antibiotics (Basel)       Date:  2022-02-15

Review 4.  Antimicrobial Susceptibility Testing: A Comprehensive Review of Currently Used Methods.

Authors:  Ina Gajic; Jovana Kabic; Dusan Kekic; Milos Jovicevic; Marina Milenkovic; Dragana Mitic Culafic; Anika Trudic; Lazar Ranin; Natasa Opavski
Journal:  Antibiotics (Basel)       Date:  2022-03-23

5.  Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia.

Authors:  Yorgo Zahlanie; Brenton C Hall; Wenjing Wei; Norman S Mang; Jessica K Ortwine; Shelby Anderson; Kristi Morgan; Tamara P Guzman; Linda S Hynan; Bonnie C Prokesch
Journal:  Infect Control Hosp Epidemiol       Date:  2021-01-11       Impact factor: 3.254

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.